文献类型： 外文期刊

第一作者： Banerjee, Moumita

作者： Banerjee, Moumita;Gao, Yingnyu;Huang, Minqi;Cai, Liquan;Sanabria, Juan;Xie, Zijian;Pierre, Sandrine V.;Li, Zhichuan;Lai, Fangfang;Zhang, Zhongbing;Gao, Yingnyu;Lai, Fangfang;Zhang, Zhongbing;Sanabria, Juan;Gao, Tianyan

作者机构：

关键词： EMT; inverse agonist; metastasis; Na/K-ATPase; prostate cancer

期刊名称：PROSTATE （ 影响因子：3.279； 五年影响因子：3.288 ）

ISSN： 0270-4137

年卷期：

页码：

收录情况： SCI

摘要： The surface expression of Na/K-ATPase alpha 1 (NKA) is significantly reduced in primary prostate tumors and further decreased in bone metastatic lesions. Here, we show that the loss of cell surface expression of NKA induces epithelial-mesenchymal transition (EMT) and promotes metastatic potential and tumor growth of prostate cancer (PCa) by decreasing the expression of E-cadherin and increasing c-Myc expression via the activation of Src/FAK pathways. Mechanistically, reduced surface expression of NKA in PCa is due to increased endocytosis through the activation of NKA/Src receptor complex. Using a high-throughput NKA ligand-screening platform, we have discovered MB5 as an inverse agonist of the NKA/Src receptor complex, capable of blocking the endocytosis of NKA. MB5 treatment increased NKA expression and E-cadherin in PCa cells, which reversed EMT and consequently decreased the invasion and growth of spheroid models and tumor xenografts. Thus, we have identified a hitherto unrecognized mechanism that regulates EMT and invasiveness of PCa and demonstrated for the first time the feasibility of identifying inverse agonists of receptor NKA/Src complex and their potential utility as anticancer drugs. We, therefore, conclude that cell surface expression of alpha 1 NKA can be targeted for the development of new therapeutics against aggressive PCa and that MB5 may serve as a prototype for drug development against EMT in metastatic PCa.

分类号：